Shares of CSL Limited (OTCMKTS:CSLLY - Get Free Report) traded up 1.3% on Tuesday . The company traded as high as $80.96 and last traded at $80.78. 112,548 shares traded hands during mid-day trading, an increase of 18% from the average session volume of 95,379 shares. The stock had previously closed at $79.75.
CSL Trading Up 0.3%
The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.97 and a current ratio of 2.18. The company has a 50-day simple moving average of $77.97 and a two-hundred day simple moving average of $83.13.
CSL Company Profile
(
Get Free Report)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Featured Stories
Before you consider CSL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.
While CSL currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
